DecisionPoint Financial
MRNA icon

DecisionPoint Financial’s Moderna MRNA Stock Holding History

DecisionPoint Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.7K Buy
9
+4
+80% +$431 ﹤0.01% 422
2026
Q2 		$363 Buy
+5
New +$259 ﹤0.01% 740
2025
Q2 		– Sell
-31
Closed -$879 – 667
2025
Q1 		$879 Hold
31
– – ﹤0.01% 226
2024
Q4 		$1.29K Buy
+31
New +$1.48K ﹤0.01% 231

Other funds holding MRNA

Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Beau Ventures
Beau Ventures Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Leonteq Securities AG
Leonteq Securities AG Zurich, Switzerland $2.44B AUM 50.17% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
State of Michigan Retirement System
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return

DecisionPoint Financial's MRNA Position: Q3 2026 in Review

DecisionPoint Financial increased its Moderna (MRNA) stake by 80% in Q3 2026, buying an estimated $431 and bringing the position to 9 shares worth $1.7K. The position accounts for ﹤0.01% of the portfolio, ranked #422.

DecisionPoint Financial first reported a position in MRNA in Q4 2024 and has held it in 4 quarters since. 330 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • DecisionPoint Financial held 9 shares of Moderna worth $1.7K as of Q3 2026.
  • DecisionPoint Financial bought 4 Moderna shares in Q3 2026, an estimated $431.
  • Moderna made up ﹤0.01% of DecisionPoint Financial's portfolio in Q3 2026, its #422 holding.
  • DecisionPoint Financial first reported a position in Moderna in Q4 2024 and has held it in 4 quarters since.
  • 330 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on DecisionPoint Financial's 13F filing for Q3 2026, filed 27 Oct 2026.